Molecular mechanisms of axon degeneration
Molecular mechanisms of axon degeneration
批准号:
9763955
负责人:
Marc R Freeman
金额:
$33.69万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2024-02-29
关键词:
AcuteAddressAdultAnimalsApoptoticAreaAxonAxonal TransportAxotomyBiological AssayBiologyBrainCa(2+)-Calmodulin Dependent Protein KinaseCell DeathCell physiologyCellsCellular biologyCessation of lifeChemotherapy-induced peripheral neuropathyComplexDataDiseaseDistalDrosophila genusEventExhibitsFiberFunctional disorderFundingGenesGeneticGenetic studyGoalsGrantHigh Fat DietHourHumanImageInflammationInjuryKnockout MiceLasersLeadLong-Term EffectsMAP Kinase GeneMammalsMediatingMethodologyModelingMolecularMolecular GeneticsMorphologyMusNerveNerve CrushNerve DegenerationNervous System TraumaNervous system structureNeurogliaNeuronsNeuropathyNeurophysiology - biologic functionOutcomePathway interactionsPhasePhysiologyPlayProcessProtocols documentationRegulationReproducibilityResolutionRoleSensorySeriesSeveritiesSignal PathwaySignal TransductionSignaling MoleculeSynapsesTherapeuticTherapeutic InterventionTimeTissuesTraumaTraumatic Brain InjuryWallerian DegenerationWingWorkaxon injuryaxonal degenerationcalmodulin-dependent protein kinase IIdriving forceexperimental studyflygenetic manipulationin vivoinjuredinsightloss of functionmutantnerve injurynervous system disorderneural circuitneuronal cell bodyneuropathologyneurophysiologyneurotransmissionnovelreceptorrelating to nervous systemresponseresponse to injurysuccesstherapeutic candidate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nervous system injury can have devastating long-term effects on brain or nerve function, yet signaling pathways that
regulate nervous system responses to injury, especially in early acute phases, remain poorly defined. In our previous work we sought to identify molecules required to drive axon degeneration after axotomy and identified dSarm/Sarm1 as a key signaling molecule that drives axon auto-destruction. In dsarm/Sarm1 null mutant flies or mice, severed distal axons do not degenerate and remain morphologically intact for weeks after injury. Understanding how dSarm/Sarm1 signals in axons is now a major focus for the field, but the vast majority of studies have focused on the final outcome of axotomy—axonal degeneration—which occurs many hours to days after axotomy. In preliminary work we discovered that nerve
injury leads to rapid changes (within 2-3 hrs after injury) in axon transport in both severed axons and adjacent intact
neurons, and a suppression of sensory signal transduction in intact neurons throughout the nerve. We wish to understand
how injury signals spread throughout the nerve so quickly to activate these response (which we refer to as Phase 1
responses), and the roles that neurons and glia play in this process. Interestingly, we found that components of the dSarm
signaling pathway, the Ca2+-driven Unc-76→Cacophony→CamK-II→dSarm signaling pathway, and components of the
MAPK pathway play important roles within 3 hrs after injury to alter axonal cell biology and function. In addition, we
found that the glial receptor Draper/MEGF10, functions in glia to activate Phase 1 responses in intact neurons (but not
severed neurons) within 3 hrs after injury. In Aim 1 we will characterize this novel role for dSarm/Sarm1 and the axon
death signaling machinery in regulation of early (Phase 1) responses in intact neurons and severed axons in a simple,
genetically-tractable injured nerved, and how these signaling events alter neurophysiology. In Aim 2 we will perform
similar studies to explore a novel role for the Unc-76→Cacophony→CamK-II→dSarm signaling pathway and MAPK
signaling in axonal Phase 1 responses to nerve injury. In Aim 3 we will determine how nerve injury severity regulates
neuronal and glial responses to injury, and how the Draper signaling pathway helps spread injury signals along a nerve to
modulate nerve-wide changes in axon physiology. This work will provide important new insights into how axon death
signaling molecules regulate acute responses to nerve injury, identify new molecules involved in injury signaling (Unc-76,
Cacophony, CamK-II), clarify how MAPK signaling drives changes in axon biology after injury, and delineate exciting
new roles for Draper/MEGF10 during the acute window of nerve responses to injury. Given that dSarm/Sarm1 and
Draper/MEGF10 signaling pathways (and their functional roles) are highly conserved, our work will illuminate
fundamental mechanisms of nervous system injury signaling that should have high relevance to human neural injury and neurological disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
How do you build an astrocyte?
-
批准号:10646059
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2023
-
负责人:Marc R Freeman
-
依托单位:
2023 Glial Biology: Functional Interactions Among Glia and Neurons Gordon Research Conference and Gordon Research Seminar
-
批准号:10609354
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2022
-
负责人:Marc R Freeman
-
依托单位:
Landis Award for Outstanding Mentorship
-
批准号:10661432
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2022
-
负责人:Marc R Freeman
-
依托单位:
Molecular pathways regulating astrocyte morphogenesis and function
-
批准号:10645162
-
项目类别:
-
资助金额:$49.07万
-
财政年份:2021
-
负责人:Marc R Freeman
-
依托单位:
Molecular pathways regulating astrocyte morphogenesis and function
-
批准号:10454296
-
项目类别:
-
资助金额:$49.07万
-
财政年份:2021
-
负责人:Marc R Freeman
-
依托单位:
Molecular pathways regulating astrocyte morphogenesis and function
-
批准号:10316938
-
项目类别:
-
资助金额:$49.07万
-
财政年份:2021
-
负责人:Marc R Freeman
-
依托单位:
How do non-myelinating glia ensheath axons?
-
批准号:10617726
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2019
-
负责人:Marc R Freeman
-
依托单位:
How do non-myelinating glia ensheath axons?
-
批准号:10397991
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2019
-
负责人:Marc R Freeman
-
依托单位:
How do non-myelinating glia ensheath axons?
-
批准号:9797524
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2019
-
负责人:Marc R Freeman
-
依托单位:
Characterizing new genes that govern mitochondrial function in the axon
-
批准号:9272960
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2016
-
负责人:Marc R Freeman
-
依托单位:
Characterizing new genes that govern mitochondrial function in the axon
-
批准号:9168491
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Marc R Freeman
-
依托单位:
How does Wlds protect severed axons?
-
批准号:7465298
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
Molecular Mechanisms of Axon Degeneration
-
批准号:9491445
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
Molecular Mechanisms of Axon Degeneration
-
批准号:8629310
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
How does Wlds protect severed axons?
-
批准号:7797358
-
项目类别:
-
资助金额:$35.19万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
Molecular mechanisms of axon degeneration
-
批准号:10374761
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
How does Wlds protect severed axons?
-
批准号:8039180
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
How does Wlds protect severed axons?
-
批准号:8235916
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
How does Wlds protect severed axons?
-
批准号:7563926
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
Molecular mechanisms of axon degeneration
-
批准号:10604338
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2008
-
负责人:Marc R Freeman
-
依托单位:
海外基金